Dr Didem Torumkuney


Scientific Director for Infectious Diseases Research at GlaxoSmithKline (GSK). Completed her PhD at the Medical Faculty in Istanbul in collaboration with the UK Health Security Agency (Public Health England-Colindale) on effect of environmental factors on AMR. She has 17 years antibiotic surveillance experience in different countries/regions. Didem’s research focuses on: AMR, global antibiotic surveillance studies, and antibiotic development. Currently, she works as clinical microbiology lead for tebipenem development at GSK.